Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LOS ANGELES--(BUSINESS WIRE)--NuScale Power Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SMR...

NEW HAVEN, Conn.--(BUSINESS WIRE)--On November 9–10, the inaugural Future of Oncology Summit brought together over 500 leaders from academia, biotechnology, pharmaceuticals, investment, and the broader oncology ecosystem at 101 College Street in New Haven. The two-day event featured more than 70 speakers, including keynote speakers Clifford Hudis, MD, CEO of the American Society of Clinical Oncology (ASCO), and Annie Lamont, co-founder and managing partner of Oak HC/FT, as well as remarks from...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

大阪＆東京--(BUSINESS WIRE)--（ビジネスワイヤ） -- タンジェMED港と株式会社三井住友銀行（SMBC）は、住友商事の後援を受けて「Japan Roadshow 2026」 を主催し、大阪および東京において商談会を開催しました。この取り組みは、タンジェMEDに集約されている港湾・物流・産業の拠点における投資機会を紹介するとともに、特に自動車、航空宇宙、電子機器、物流、再生可能エネルギーの各分野における貿易および産業協力を促進し、モロッコと日本の経済・産業面での結びつきを強化することを狙いとしています。 この訪日旅行商談会は、サプライチェーンの統合、技術移転、持続可能な製造を促進する一方で、日本を代表する企業との直接的なやり取りや商談の円滑化の後押しとなりました。 タンジェMED港は、東西を結ぶ主要な海上航路の交差点であるジブラルタル海峡に位置し、欧州、アフリカをはじめとする世界各地の市場へのアクセスを提供しています。世界180以上の港を繋ぐタンジェMEDの港湾複合施設における2025年の貨物取扱高は1,110万TEU超、1億6,100万トンにのぼり、アフリカおよび...